WallStreetZenWallStreetZen

NASDAQ: NRC
National Research Corp Stock

$39.40-0.30 (-0.76%)
Updated Mar 27, 2024
NRC Price
$39.40
Fair Value Price
$27.42
Market Cap
$939.86M
52 Week Low
$36.21
52 Week High
$47.25
P/E
31.27x
P/B
19.2x
P/S
6.53x
PEG
13.7x
Dividend Yield
4.06%
Revenue
$148.58M
Earnings
$30.97M
Gross Margin
62.3%
Operating Margin
27.48%
Profit Margin
20.8%
Debt to Equity
1.5
Operating Cash Flow
$38M
Beta
0.96
Next Earnings
Apr 30, 2024
Ex-Dividend
Mar 27, 2024
Next Dividend
Apr 15, 2024

NRC Overview

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NRC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NRC ($39.40) is overvalued by 43.68% relative to our estimate of its Fair Value price of $27.42 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
NRC ($39.40) is not significantly undervalued (43.68%) relative to our estimate of its Fair Value price of $27.42 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NRC ($39.40) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more NRC due diligence checks available for Premium users.

Be the first to know about important NRC news, forecast changes, insider trades & much more!

NRC News

Valuation

NRC fair value

Fair Value of NRC stock based on Discounted Cash Flow (DCF)
Price
$39.40
Fair Value
$27.42
Overvalued by
43.68%
NRC ($39.40) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NRC ($39.40) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NRC ($39.40) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NRC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
31.27x
Industry
80.7x
Market
44.45x
NRC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NRC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

NRC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
19.2x
Industry
3.73x
NRC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NRC price to earnings growth (PEG)

For valuing profitable companies with growth potential
NRC is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

NRC's financial health

Profit margin

Revenue
$38.0M
Net Income
$8.9M
Profit Margin
23.3%
NRC's Earnings (EBIT) of $40.82M... subscribe to Premium to read more.
Interest Coverage Financials
NRC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$122.4M
Liabilities
$73.5M
Debt to equity
1.5
NRC's short-term liabilities ($36.20M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NRC's long-term liabilities ($37.28M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NRC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NRC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$11.7M
Investing
-$3.8M
Financing
-$5.1M
NRC's operating cash flow ($38.11M)... subscribe to Premium to read more.
Debt Coverage Financials

NRC vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
NRC$939.86M-0.76%31.27x19.20x
SLP$825.64M+0.71%76.57x4.79x
HSTM$786.60M-0.80%51.92x2.31x
ACCD$773.30M+0.30%-6.20x1.78x
DH$1.24B+1.67%-4.42x1.44x

National Research Stock FAQ

What is National Research's quote symbol?

(NASDAQ: NRC) National Research trades on the NASDAQ under the ticker symbol NRC. National Research stock quotes can also be displayed as NASDAQ: NRC.

If you're new to stock investing, here's how to buy National Research stock.

What is the 52 week high and low for National Research (NASDAQ: NRC)?

(NASDAQ: NRC) National Research's 52-week high was $47.25, and its 52-week low was $36.21. It is currently -16.61% from its 52-week high and 8.82% from its 52-week low.

How much is National Research stock worth today?

(NASDAQ: NRC) National Research currently has 23,854,428 outstanding shares. With National Research stock trading at $39.40 per share, the total value of National Research stock (market capitalization) is $939.86M.

National Research stock was originally listed at a price of $2.21 in Dec 31, 1997. If you had invested in National Research stock at $2.21, your return over the last 26 years would have been 1,684.42%, for an annualized return of 11.72% (not including any dividends or dividend reinvestments).

How much is National Research's stock price per share?

(NASDAQ: NRC) National Research stock price per share is $39.40 today (as of Mar 27, 2024).

What is National Research's Market Cap?

(NASDAQ: NRC) National Research's market cap is $939.86M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

National Research's market cap is calculated by multiplying NRC's current stock price of $39.40 by NRC's total outstanding shares of 23,854,428.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.